RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Efficacy and safety of novel sodium glucose cotransporter-2 inhibitor remogliflozin in the management of type 2 diabetes mellitus: A systematic review and meta-analysis.

Efficacy and safety of novel sodium glucose cotransporter-2 inhibitor remogliflozin in the management of type 2 diabetes mellitus: A systematic review and meta-analysis.

Add to Collection
2021 Nov-Dec Systematic Review and Meta Analysis D Dutta, R Jindal, D Mehta, D Khandelwal… - Diabetes & Metabolic …, 2021 - Elsevier

Full Author : ['Dutta, Deep', 'Jindal, Radhika', 'Mehta, Divij', 'Khandelwal, Deepak', 'Sharma, Meha']
Journal Title : Diabetes & metabolic syndrome
Chapter : Section3
Journal Year : 2021
Cited by : 2.0

BACKGROUND AND AIMS: No meta-analysis has analysed efficacy and safety of remogliflozin. We undertook this meta-analysis to address this gap in knowledge METHODS: Electronic databases were searched for RCTs involving diabetes patients receiving remogliflo..... Read More

Keywords : ["novel sodium glucose inhibitor remogliflozin", "type diabetes mellitus", "systematic review", "safety", "metaanalysis", "management", "efficacy"]
PubMed Link : https://www.sciencedirect.com/science/article/pii/S1871402121003350
Google Scholar Link : https://scholar.google.com/scholar?cites=5091786653281533481&as_sdt=2005&sciodt=0,5&hl=en&num=20